[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2020-2026

July 2020 | 94 pages | ID: C2404A6BCC3DEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Exosome Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exosome Diagnostics and Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Aethlon Medical(US)
  • Exosome Diagnostics(US)
  • NanoSomix Inc.(US)
  • Thermo Fisher Scientific (US)
  • Malvern Instruments (UK)
  • System Biosciences(US)
  • NX Pharmagen (US)
  • Sistemic Inc(UK)
  • Capricor Therapeutics (US)
  • Exiqon A/S (Denmark)
Market segment by Type, the product can be split into
  • Instrument
  • Reagent
  • Software
Market segment by Application, split into
  • Diagnostic
  • Therapeutic
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Exosome Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the Exosome Diagnostics and Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Exosome Diagnostics and Therapeutics are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Exosome Diagnostics and Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Instrument
  1.4.3 Reagent
  1.4.4 Software
1.5 Market by Application
  1.5.1 Global Exosome Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Diagnostic
  1.5.3 Therapeutic
1.6 Coronavirus Disease 2019 (Covid-19): Exosome Diagnostics and Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Exosome Diagnostics and Therapeutics Industry
    1.6.1.1 Exosome Diagnostics and Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Exosome Diagnostics and Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Exosome Diagnostics and Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Exosome Diagnostics and Therapeutics Market Perspective (2015-2026)
2.2 Exosome Diagnostics and Therapeutics Growth Trends by Regions
  2.2.1 Exosome Diagnostics and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Exosome Diagnostics and Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Exosome Diagnostics and Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Exosome Diagnostics and Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Exosome Diagnostics and Therapeutics Players by Market Size
  3.1.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio
  3.2.1 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Exosome Diagnostics and Therapeutics Revenue in 2019
3.3 Exosome Diagnostics and Therapeutics Key Players Head office and Area Served
3.4 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
3.5 Date of Enter into Exosome Diagnostics and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2021-2026)

5 EXOSOME DIAGNOSTICS AND THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)
5.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Exosome Diagnostics and Therapeutics Market Size (2015-2020)
6.2 Exosome Diagnostics and Therapeutics Key Players in North America (2019-2020)
6.3 North America Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
6.4 North America Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Exosome Diagnostics and Therapeutics Market Size (2015-2020)
7.2 Exosome Diagnostics and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Exosome Diagnostics and Therapeutics Market Size (2015-2020)
8.2 Exosome Diagnostics and Therapeutics Key Players in China (2019-2020)
8.3 China Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
8.4 China Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Exosome Diagnostics and Therapeutics Market Size (2015-2020)
9.2 Exosome Diagnostics and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Exosome Diagnostics and Therapeutics Market Size (2015-2020)
10.2 Exosome Diagnostics and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Exosome Diagnostics and Therapeutics Market Size (2015-2020)
11.2 Exosome Diagnostics and Therapeutics Key Players in India (2019-2020)
11.3 India Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
11.4 India Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Exosome Diagnostics and Therapeutics Market Size (2015-2020)
12.2 Exosome Diagnostics and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Aethlon Medical(US)
  13.1.1 Aethlon Medical(US) Company Details
  13.1.2 Aethlon Medical(US) Business Overview and Its Total Revenue
  13.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Introduction
  13.1.4 Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020))
  13.1.5 Aethlon Medical(US) Recent Development
13.2 Exosome Diagnostics(US)
  13.2.1 Exosome Diagnostics(US) Company Details
  13.2.2 Exosome Diagnostics(US) Business Overview and Its Total Revenue
  13.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Introduction
  13.2.4 Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.2.5 Exosome Diagnostics(US) Recent Development
13.3 NanoSomix Inc.(US)
  13.3.1 NanoSomix Inc.(US) Company Details
  13.3.2 NanoSomix Inc.(US) Business Overview and Its Total Revenue
  13.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Introduction
  13.3.4 NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.3.5 NanoSomix Inc.(US) Recent Development
13.4 Thermo Fisher Scientific (US)
  13.4.1 Thermo Fisher Scientific (US) Company Details
  13.4.2 Thermo Fisher Scientific (US) Business Overview and Its Total Revenue
  13.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Introduction
  13.4.4 Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.4.5 Thermo Fisher Scientific (US) Recent Development
13.5 Malvern Instruments (UK)
  13.5.1 Malvern Instruments (UK) Company Details
  13.5.2 Malvern Instruments (UK) Business Overview and Its Total Revenue
  13.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Introduction
  13.5.4 Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.5.5 Malvern Instruments (UK) Recent Development
13.6 System Biosciences(US)
  13.6.1 System Biosciences(US) Company Details
  13.6.2 System Biosciences(US) Business Overview and Its Total Revenue
  13.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Introduction
  13.6.4 System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.6.5 System Biosciences(US) Recent Development
13.7 NX Pharmagen (US)
  13.7.1 NX Pharmagen (US) Company Details
  13.7.2 NX Pharmagen (US) Business Overview and Its Total Revenue
  13.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Introduction
  13.7.4 NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.7.5 NX Pharmagen (US) Recent Development
13.8 Sistemic Inc(UK)
  13.8.1 Sistemic Inc(UK) Company Details
  13.8.2 Sistemic Inc(UK) Business Overview and Its Total Revenue
  13.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Introduction
  13.8.4 Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.8.5 Sistemic Inc(UK) Recent Development
13.9 Capricor Therapeutics (US)
  13.9.1 Capricor Therapeutics (US) Company Details
  13.9.2 Capricor Therapeutics (US) Business Overview and Its Total Revenue
  13.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Introduction
  13.9.4 Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.9.5 Capricor Therapeutics (US) Recent Development
13.10 Exiqon A/S (Denmark)
  13.10.1 Exiqon A/S (Denmark) Company Details
  13.10.2 Exiqon A/S (Denmark) Business Overview and Its Total Revenue
  13.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Introduction
  13.10.4 Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020)
  13.10.5 Exiqon A/S (Denmark) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Exosome Diagnostics and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Exosome Diagnostics and Therapeutics Revenue
Table 3. Ranking of Global Top Exosome Diagnostics and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instrument
Table 6. Key Players of Reagent
Table 7. Key Players of Software
Table 8. COVID-19 Impact Global Market: (Four Exosome Diagnostics and Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Exosome Diagnostics and Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Exosome Diagnostics and Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Exosome Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Exosome Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Exosome Diagnostics and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Exosome Diagnostics and Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Exosome Diagnostics and Therapeutics Players
Table 24. Global Exosome Diagnostics and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Exosome Diagnostics and Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2019)
Table 27. Global Exosome Diagnostics and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
Table 30. Date of Enter into Exosome Diagnostics and Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Exosome Diagnostics and Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Exosome Diagnostics and Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Exosome Diagnostics and Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 40. North America Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 42. North America Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 46. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 52. China Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 54. China Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 58. Japan Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 70. India Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 72. India Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Exosome Diagnostics and Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Exosome Diagnostics and Therapeutics Market Share (2019-2020)
Table 76. Central & South America Exosome Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Exosome Diagnostics and Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Exosome Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Exosome Diagnostics and Therapeutics Market Share by Application (2015-2020)
Table 80. Aethlon Medical(US) Company Details
Table 81. Aethlon Medical(US) Business Overview
Table 82. Aethlon Medical(US) Product
Table 83. Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 84. Aethlon Medical(US) Recent Development
Table 85. Exosome Diagnostics(US) Company Details
Table 86. Exosome Diagnostics(US) Business Overview
Table 87. Exosome Diagnostics(US) Product
Table 88. Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 89. Exosome Diagnostics(US) Recent Development
Table 90. NanoSomix Inc.(US) Company Details
Table 91. NanoSomix Inc.(US) Business Overview
Table 92. NanoSomix Inc.(US) Product
Table 93. NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 94. NanoSomix Inc.(US) Recent Development
Table 95. Thermo Fisher Scientific (US) Company Details
Table 96. Thermo Fisher Scientific (US) Business Overview
Table 97. Thermo Fisher Scientific (US) Product
Table 98. Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 99. Thermo Fisher Scientific (US) Recent Development
Table 100. Malvern Instruments (UK) Company Details
Table 101. Malvern Instruments (UK) Business Overview
Table 102. Malvern Instruments (UK) Product
Table 103. Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 104. Malvern Instruments (UK) Recent Development
Table 105. System Biosciences(US) Company Details
Table 106. System Biosciences(US) Business Overview
Table 107. System Biosciences(US) Product
Table 108. System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 109. System Biosciences(US) Recent Development
Table 110. NX Pharmagen (US) Company Details
Table 111. NX Pharmagen (US) Business Overview
Table 112. NX Pharmagen (US) Product
Table 113. NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 114. NX Pharmagen (US) Recent Development
Table 115. Sistemic Inc(UK) Business Overview
Table 116. Sistemic Inc(UK) Product
Table 117. Sistemic Inc(UK) Company Details
Table 118. Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 119. Sistemic Inc(UK) Recent Development
Table 120. Capricor Therapeutics (US) Company Details
Table 121. Capricor Therapeutics (US) Business Overview
Table 122. Capricor Therapeutics (US) Product
Table 123. Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 124. Capricor Therapeutics (US) Recent Development
Table 125. Exiqon A/S (Denmark) Company Details
Table 126. Exiqon A/S (Denmark) Business Overview
Table 127. Exiqon A/S (Denmark) Product
Table 128. Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2015-2020) (Million US$)
Table 129. Exiqon A/S (Denmark) Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Exosome Diagnostics and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Instrument Features
Figure 3. Reagent Features
Figure 4. Software Features
Figure 5. Global Exosome Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Case Studies
Figure 7. Therapeutic Case Studies
Figure 8. Exosome Diagnostics and Therapeutics Report Years Considered
Figure 9. Global Exosome Diagnostics and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Exosome Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Exosome Diagnostics and Therapeutics Market Share by Players in 2019
Figure 14. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Exosome Diagnostics and Therapeutics Revenue in 2019
Figure 16. North America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Aethlon Medical(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Aethlon Medical(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 25. Exosome Diagnostics(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Exosome Diagnostics(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 27. NanoSomix Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. NanoSomix Inc.(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 29. Thermo Fisher Scientific (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Thermo Fisher Scientific (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 31. Malvern Instruments (UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Malvern Instruments (UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 33. System Biosciences(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. System Biosciences(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 35. NX Pharmagen (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. NX Pharmagen (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 37. Sistemic Inc(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sistemic Inc(UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 39. Capricor Therapeutics (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Capricor Therapeutics (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 41. Exiqon A/S (Denmark) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Exiqon A/S (Denmark) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed


More Publications